Could a light cap boost your memory?

NCT ID NCT06618807

Recruiting now Symptom relief Sponsor: Unity Health Toronto Source: ClinicalTrials.gov ↗

First seen Jan 08, 2026 · Last updated May 20, 2026 · Updated 17 times

Summary

This study tests a non-invasive light therapy device (Neuro RX Gamma) for people with mild cognitive impairment (MCI) due to Alzheimer's disease. It aims to see if the treatment is safe, feasible, and can improve memory and thinking. About 60 adults aged 50 and older with MCI will receive near-infrared light to specific brain areas over several sessions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT (MCI) DUE TO ALZHEIMER'S DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

St. Michael's Hospital, Unity Health Toronto
RECRUITING

Toronto, Ontario, M5B 1T8, Canada

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MILD COGNITIVE IMPAIRMENT (MCI) DUE TO ALZHEIMER'S DISEASE